Anebulo Pharmaceuticals Inc (ANEB)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.81M | -2.86M | -2.49M | -2.54M | -2.76M | -1.66M | -1.34M | -2.41M |
| Pre Tax Income | -3.83M | -2.8M | -2.5M | -2.48M | -2.72M | -1.65M | -1.35M | -2.2M |
| Net Income | -3.83M | -2.8M | -2.5M | -2.48M | -2.72M | -1.65M | -1.35M | -2.2M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -3.83M | -2.81M | -2.54M | -2.54M | -2.76M | -1.66M | -1.34M | -2.17M |
| EBITDA | -3.81M | -2.86M | -2.49M | -2.54M | -2.76M | -1.66M | -1.34M | -2.41M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -174k | -3.61M | -6.83M | -11.78M | -8.31M |
| Pre Tax Income | -175k | -30.25M | -6.83M | -11.73M | -8.2M |
| Net Income | -175k | -38.46M | -6.83M | -11.73M | -8.2M |
| Preferred Dividends | 0 | -8.21M | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.088 | -1.515 | -0.269 | -0.424 | -0.293 |
| EBIT | -174k | -3.62M | -6.83M | -11.82M | -8.3M |
| EBITDA | -174k | -3.61M | -6.83M | -11.78M | -8.31M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
